Published in Cardiovasc Drugs Ther on October 01, 2013
Long QT Syndrome: An Emerging Role for Inflammation and Immunity. Front Cardiovasc Med (2015) 0.84
Pitavastatin regulates helper T-cell differentiation and ameliorates autoimmune myocarditis in mice. Cardiovasc Drugs Ther (2013) 1.38
Statins and the joint: multiple targets for a global protection? Semin Arthritis Rheum (2010) 1.97
MF59-adjuvanted H5N1 vaccine induces immunologic memory and heterotypic antibody responses in non-elderly and elderly adults. PLoS One (2009) 1.79
Prolongation of the corrected QT interval in adult patients with anti-Ro/SSA-positive connective tissue diseases. Arthritis Rheum (2004) 1.59
Autoantibody-mediated cardiac arrhythmias: mechanisms and clinical implications. Basic Res Cardiol (2007) 1.26
Connective tissue diseases and cardiac rhythm disorders: an overview. Autoimmun Rev (2005) 1.25
Hyperhomocysteinemia, inflammation and autoimmunity. Autoimmun Rev (2007) 1.11
A heterologous MF59-adjuvanted H5N1 prepandemic influenza booster vaccine induces a robust, cross-reactive immune response in adults and the elderly. Clin Vaccine Immunol (2010) 1.04
Changes of peripheral A2A adenosine receptors in chronic heart failure and cardiac transplantation. FASEB J (2002) 0.94
One dose of an MF59-adjuvanted pandemic A/H1N1 vaccine recruits pre-existing immune memory and induces the rapid rise of neutralizing antibodies. Vaccine (2012) 0.91
Association between high sensitivity C-reactive protein, heart rate variability and corrected QT interval in patients with chronic inflammatory arthritis. Eur J Intern Med (2013) 0.90
Human rheumatoid synoviocytes express functional P2X7 receptors. J Mol Med (Berl) (2008) 0.89
Psychosine-induced apoptosis and cytokine activation in immune peripheral cells of Krabbe patients. J Cell Physiol (2007) 0.89
Systemic inflammation and arrhythmic risk: lessons from rheumatoid arthritis. Eur Heart J (2017) 0.86
Alteration in the redox state of plasma in heart-transplant patients with moderate hyperhomocysteinemia. J Lab Clin Med (2003) 0.86
Adenosine A2A receptor activation stimulates collagen production in sclerodermic dermal fibroblasts either directly and through a cross-talk with the cannabinoid system. J Mol Med (Berl) (2011) 0.86
Synthetic cannabinoid ajulemic acid exerts potent antifibrotic effects in experimental models of systemic sclerosis. Ann Rheum Dis (2012) 0.82
Upregulation of A2A adenosine receptor expression by TNF-alpha in PBMC of patients with CHF: a regulatory mechanism of inflammation. J Card Fail (2005) 0.82
Anti-Ro/SSA-associated corrected QT interval prolongation in adults: the role of antibody level and specificity. Arthritis Care Res (Hoboken) (2011) 0.82
Arrhythmogenic effects of anti-Ro/SSA antibodies on the adult heart: more than expected? Autoimmun Rev (2009) 0.82
The effects of age and hyperhomocysteinemia on the redox forms of plasma thiols. J Lab Clin Med (2004) 0.81
Comparison of frequency of complex ventricular arrhythmias in patients with positive versus negative anti-Ro/SSA and connective tissue disease. Am J Cardiol (2007) 0.81
The purinergic P2×7 receptor is expressed on monocytes in Behçet's disease and is modulated by TNF-α. Eur J Immunol (2013) 0.80
Antiarrhythmic potential of anticytokine therapy in rheumatoid arthritis: tocilizumab reduces corrected QT interval by controlling systemic inflammation. Arthritis Care Res (Hoboken) (2015) 0.80
Cannabinoids inhibit fibrogenesis in diffuse systemic sclerosis fibroblasts. Rheumatology (Oxford) (2009) 0.79
Familial Mediterranean fever diagnosed in an elderly patient. Clin Exp Rheumatol (2010) 0.79
Chronic protection against ischemia and reperfusion-induced endothelial dysfunction during therapy with different organic nitrates. Clin Res Cardiol (2012) 0.79
Arrhythmic risk during acute infusion of infliximab: a prospective, single-blind, placebo-controlled, crossover study in patients with chronic arthritis. J Rheumatol (2008) 0.78
Homocysteine and Raynaud's phenomenon: a review. Autoimmun Rev (2009) 0.78
AMPD1 (C34T) polymorphism and clinical outcomes in patients undergoing myocardial revascularization. Int J Cardiol (2005) 0.78
Homocysteine and P wave dispersion in patients with heart transplantation. Clin Transplant (2011) 0.78
Oral low-dose dipyridamole protects from intravenous high-dose dipyridamole-induced ischemia. A stress echocardiographic study. Int J Cardiol (2002) 0.78
Levels of circulating CXCR4-positive cells are decreased and negatively correlated with risk factors in cardiac transplant recipients. Heart Vessels (2010) 0.77
The "invulnerability" of the adult conduction system to anti-Ro/SSA antibodies? A matter of calcium channel expression on the cardiomyocyte. J Cardiovasc Electrophysiol (2011) 0.77
Adenosine A2(A) receptor gene polymorphism (1976C>T) affects coronary flow reserve response during vasodilator stress testing in patients with non ischemic-dilated cardiomyopathy. Pharmacogenet Genomics (2011) 0.76
Using peripheral blood mononuclear cells to determine proteome profiles in human cardiac failure. Eur J Heart Fail (2008) 0.76
Rosuvastatin inhibits spontaneous and IL-1β-induced interleukin-6 production from human cultured osteoblastic cells. Joint Bone Spine (2012) 0.76
Comment on: letter to the editor from Clockaerts and Bierma-Zeinstra. Semin Arthritis Rheum (2011) 0.75
Cyclosporin and tacrolimus increase plasma levels of adenosine in kidney transplanted patients. Transpl Int (2005) 0.75
Combination Therapy With Ceftriaxone and Lansoprazole, Acquired Long QT Syndrome, and Torsades de Pointes Risk. J Am Coll Cardiol (2017) 0.75